All In Biotech

Drug Trial Radar · NCT00168636

Different Doses of Vitamin A Supplementation and Male and Female Morbidity and Mortality

The Impact of Different Doses of Vitamin A Supplementation on Male and Female Childhood Morbidity and Mortality

Last checked: Nov 20, 2026Latest source record: Nov 15, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 11,000 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

11,000

Actual

Start

Nov 2004

Primary completion

Nov 2013

Sponsor

Lead sponsor
Bandim Health ProjectAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 15, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
All sexes, from 6 months, up to 5 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

We previously compared the effect on mortality of the half dose and the full dose currently recommended by WHO. Unexpectedly, the low dose was clearly better for girls, but not for boys. The girls' response might have depended on the last vaccine received before the OPV and VAS campaign. We believe that these findings call for confirmation. In connection with a new campaign, we will examine whether half the dose or the full dose has a more beneficial effect on mortality and morbidity in girls, and furthermore address the potential effect modification by the last vaccine received before the supplementation.

Conditions

  • Mortality
  • Morbidity

Interventions

  • Vitamin ADrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mortality
  2. Morbidity
  3. All outcomes are investigated for interactions between vitamin A, sex, and last vaccine received

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Bandim Health Project, Apartado 861

    Bissau, Guinea-Bissau

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.